Nanobiotix
Founded 2003 · 143 employees on LinkedIn · 5 known investors
Nanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
Investors · 5
Also in the syndicate · 2
StifelTD Cowen
Funding
SEC filings, press & company announcements$100M disclosed across 1 round · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nanobiotix do?
- Nanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
- Who are Nanobiotix's investors?
- Nanobiotix's investors include HEALTHCARE ROYALTY PARTNERS, Karista, Jefferies.
- How much funding has Nanobiotix raised?
- Nanobiotix has disclosed $100M raised across 1 round.

